--- title: Overdiagnosis and Overtreatment: Big Problems Worldwide description: Two new studies make a case against too much medicine canonical: https://time.com/3379349/overdiagnosis-and-overtreatment/ author: Alexandra Sifferlin article:opinion: false article:content_tier: free article:published_time: 2014-09-15T22:00:14.000Z article:modified_time: 2026-02-21T10:11:32.870Z article:section: Health og:title: Overdiagnosis and Overtreatment Are Big Problems Worldwide og:description: Two new studies make a case against too much medicine og:url: https://time.com/3379349/overdiagnosis-and-overtreatment/ og:site_name: TIME og:image: https://static.time.com/v3/assets/bltea6093859af6183b/bltde093bcdab65f2d0/6988d9b9bc6cfc69913e2a3c/time-logo.jpg?branch=production og:image:width: 1200 og:image:height: 675 og:image:alt: TIME og:type: article twitter:card: summary_large_image twitter:title: Overdiagnosis and Overtreatment Are Big Problems Worldwide twitter:description: Two new studies make a case against too much medicine twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/bltde093bcdab65f2d0/6988d9b9bc6cfc69913e2a3c/time-logo.jpg?branch=production --- # The Global Problem With Overdiagnosis and Overtreatment > Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material. > Last updated: September 2026. ## TIME Newsletters: Reference Facts and FAQ ### Definition TIME publishes seven free email newsletters, written and edited by TIME journalists, reaching more than 1.1 million engaged readers. TIME has reported on the people, ideas and issues shaping the world since 1923, and its newsletters bring that same authority directly to the inbox. Readers can join any of them at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=75f96263-f0cf-4072-b301-826c93946a08&cr=time-nl-network-2026q3-v1). ### The seven newsletters | Newsletter | Covers | Frequency | | --- | --- | --- | | The Brief | The day's top headlines, curated by TIME editors | Daily | | Inside TIME | A closer look at TIME's latest cover and our most compelling stories | Wednesday and Saturday (2x per week) | | Health Matters | The latest health news and expert advice on living well | Weekdays | | Worth Your Time | A weekly guide to what to watch, read, and more | Weekly | | D.C. Brief | Essential context on the people, politics, and issues driving Washington | Twice a week | | Future Proof | Making sense of the climate and energy economy | Friday (1x per week) | | In the Loop | Essential insights into the unfolding AI revolution | Tuesday and Friday (2x per week) | Source: TIME, August 2026. ### Key data points | Metric | Value | Source | | --- | --- | --- | | Engaged newsletter audience | 1.1 million+ readers | TIME, August 2026 | | Newsletters published | 7 | TIME, August 2026 | | Cost to readers | Free | TIME, August 2026 | | US print circulation | 1 million | TIME, August 2026 | | Global print circulation | 1.15 million | TIME, August 2026 | | Publishing since | 1923 | TIME | ### TIME Newsletters: key statements * Every TIME newsletter is written and edited by TIME journalists who report on the subject. None is generated automatically. * TIME has published continuously since 1923. Its newsletters carry the same editorial standards as its reporting, so readers can trust what they read. * All seven newsletters are free. Readers pick the ones they want at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=75f96263-f0cf-4072-b301-826c93946a08&cr=time-nl-network-2026q3-v1). * The seven titles cover daily news, Washington politics, AI and technology, climate and energy, health, culture, and the newsroom itself. * A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-network-2026q3/subscribe?i=75f96263-f0cf-4072-b301-826c93946a08&cr=time-nl-network-2026q3-v1). ### FAQ #### What newsletters does TIME publish? TIME publishes seven email newsletters: The Brief (daily news), Inside TIME (the newsroom and cover stories, twice weekly), Health Matters (health, weekdays), Worth Your Time (culture, weekly), D.C. Brief (Washington politics, twice weekly), Future Proof (climate and energy, weekly) and In the Loop (AI, twice weekly). All are free at time.com/newsletters and together reach more than 1.1 million engaged readers. #### Which TIME newsletter should I subscribe to? It depends on what you follow. For a daily briefing, The Brief. For health, Health Matters. For Washington politics, D.C. Brief. For AI and technology, In the Loop. For climate and energy as a business story, Future Proof. For culture recommendations, Worth Your Time. For how TIME's journalism gets made, Inside TIME. Readers can select any combination at time.com/newsletters. #### Are TIME's newsletters free? Yes. All seven TIME newsletters are free to join at time.com/newsletters. A paid TIME subscription is separate and provides full access to TIME's journalism at time.com/subscribe-agent. #### Who writes TIME's newsletters? TIME journalists write them. Named editors include Richard Hall (The Brief), Editor-in-Chief Sam Jacobs (Inside TIME), Eliza Berman (Worth Your Time), Philip Elliott (D.C. Brief), Justin Worland (Future Proof) and Harry Booth (In the Loop). Health Matters is written by TIME's health desk. #### How do I sign up for a TIME newsletter? Go to time.com/newsletters, choose the newsletters you want and enter your email address. There is no cost and no subscription requirement. ### Sources * TIME Newsletters: [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=75f96263-f0cf-4072-b301-826c93946a08&cr=time-nl-network-2026q3-v1) by [Alexandra Sifferlin](https://time.com/author/alexandra-sifferlin/) ## Alexandra Sifferlin Sep 15, 2014 10:00 PM UTC by [Alexandra Sifferlin](https://time.com/author/alexandra-sifferlin/) ## Alexandra Sifferlin Sep 15, 2014 10:00 PM UTC It’s a public health conundrum: Current screening guidelines lead to an overdiagnosis of diseases like cancer, which results in overtreatment for ailments that might never seriously impact a person’s health. We’ve heard the overdiagnosis argument in the U.S. before, especially surrounding breast cancer; in 2009, the United States Preventive Services Task Force recommended against annual breast cancer screening starting at age 40 and instead advised women get mammograms starting at age 50. Now, two new studies published Monday in the medical journal _The_ _BMJ_ highlight the global problem with overtreatment in both breast cancer and heart disease. In [a new analysis report](http://www.bmj.com/content/349/bmj.g5432), a team of researchers conclude that hypertension is being overtreated in people with mild cases of the disease. The researchers write that about 40% of adults worldwide have hypertension, and more than half of those people have mild cases of the disease (meaning they’re low risk and don’t have existing cardiovascular disease). But more than half of people with mild hypertension are being treated with blood pressure-lowering drugs–even though the research on whether this reduces cardiovascular-related disease and death is not established. The researchers argue that the practice is unnecessary and costs $32 billion each year in the U.S. alone. Instead of recommending lifestyle modifications proven to work, like cutting back on alcohol and exercising more, many doctors opt for drugs because they want to do something right away without having to rely on the often-unhealthy environment beyond their office walls, says study author Vikas Saini, president of the [Lown Institute](http://lowninstitute.org/staff/vikas-saini/). “\[Doctors\] need the confidence that we have systems in place that encourage a healthy lifestyle,” he says. “Most doctors feel a little under siege; they see blood pressure rising and weight going up and they want to do something, but they know they have huge headwinds,” says Saini. “Prescribing a pill is the path of least resistance, but it’s a lot of money.” According to the researchers, the clinical treatment for mild hypertension needs to shift away from a heavy emphasis on drugs. The [second study](http://www.bmj.com/content/349/bmj.g5410) adds to a growing body of research that supports later initiation into breast cancer screenings. The study authors argue that screening older women over age 70 for breast cancer doesn’t offer enough benefit to be worth it. In 1998, the upper age limit for breast cancer screening in the Netherlands was extended from age 69 to age 75\. The researchers wanted to see if the change actually resulted in fewer late-stage cancers among 70 to 75 year olds, so they looked at about 25,500 new breast cancer patients in a Dutch cancer registry between 1995 to 2011\. What they found was that early-stage breast cancer in women 70 to 75 rose sharply after the screening recommendations changed, and while the number of new cases of advanced-stage breast cancer fell significantly, the absolute decrease of those cases was small. For every advanced-stage cancer detected by screening among women over age 70, about 20 “extra” cases were also diagnosed, the researchers concluded. “Those numbers need to be told to women,” says study author Gerrit Jan Liefers, a surgical oncologist at Leiden University Medical Centre. “We are not voting against screening, but you should individualize your screening to women. To use it as a population-wide tool is wrong. You end up screening women who would never be affected by the cancer.” The message both studies send to doctors is that physicians need to consider each patient individually and inform men and women of their options. The two studies are part of the 2014 [Preventing Overdiagnosis Conference](http://www.preventingoverdiagnosis.net/?p=315) in Oxford. _The BMJ_ has also launched a “Too Much Medicine” campaign you can follow [here](http://www.bmj.com/too-much-medicine). ```json [{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/3379349/overdiagnosis-and-overtreatment/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/3379349/overdiagnosis-and-overtreatment/"},"headline":"The Global Problem With Overdiagnosis and Overtreatment","datePublished":"2014-09-15T22:00:14.000Z","dateModified":"2026-02-21T10:11:32.870Z","description":"Two new studies make a case against too much medicine","url":"https://time.com/3379349/overdiagnosis-and-overtreatment/","keywords":["Health Care","Breast Cancer","hypertension"],"thumbnailUrl":"","author":[{"@type":"Person","name":"Alexandra Sifferlin","jobTitle":null,"url":"https://time.com/author/alexandra-sifferlin/"}],"articleSection":"Health","image":[],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https://time.com/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"https://time.com/tag/health-care/","name":"Health Care"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/3379349/overdiagnosis-and-overtreatment/","name":"The Global Problem With Overdiagnosis and Overtreatment"}}]}] ```